Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Dec;44(3):301-8.
doi: 10.1007/s12160-012-9393-2.

Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: a dose-response study

Affiliations
Randomized Controlled Trial

Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: a dose-response study

Ann C Skulas-Ray et al. Ann Behav Med. 2012 Dec.

Abstract

Background: Omega-3 fatty acids reduced heart rate (HR) and blood pressure (BP) in some studies, but dose-response studies are rare, and little is known about underlying mechanisms.

Purpose: We examined effects of 0.85 g/day eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) (low dose) and 3.4 g/day EPA + DHA (high dose) on HR and systemic hemodynamics during rest, speech, and foot cold pressor tasks.

Methods: This was a dose-response, placebo-controlled, double-blind, randomized, crossover trial (8-week treatment, 6-week washout) in 26 adults.

Results: Throughout the testing sessions, HR was reduced in a dose-dependent manner. The high dose reduced BP and stroke volume and increased pre-ejection period. Reductions in BP were associated with increases in erythrocyte omega-3 fatty acids.

Conclusions: High-dose long-chain omega-3 fatty acids can reduce BP and HR, at rest and during stress. These findings suggest that at-risk populations may achieve benefits with increased omega-3 intake. The trial was registered on ClinicalTrials.gov (NCT00504309).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Omega-3 fatty acids significantly reduced heart rate, at rest and during stress. HR was dose-dependently different by treatment (p<0.0001), and this pattern was evident throughout the rest and stressor periods. Relative to placebo, mean HR (collapsing across tasks) was reduced by 2.4 bpm following the low dose (p=0.003) and 4.0 bpm following the high dose (p<0.0001). Reductions in HR were greater with the high dose vs. low dose (p=0.02). *Resting HR differed for the placebo and high dose by 4.0 bpm (p=0.004)
Fig. 2
Fig. 2
Changes in the omega-3 index significantly predicted changes in blood pressure. Change in the omega-3 index (EPA + DHA of erythrocytes) relative to placebo treatment was used as a predictor of changes in mean arterial pressure during reactivity sessions relative to placebo treatment (Minitab v.16, State College, PA). The slope of the line did not differ by treatment and the two treatments were pooled for the analysis. The regression equation is ΔMAP=2.03–1.07 Δomega-3 index

Comment in

Similar articles

Cited by

References

    1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572. - PubMed
    1. Lang CC, Gupta S, Kalra P, et al. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: Clinical evidence and pathophysiological mechanisms. Atherosclerosis. 2010;212:1–8. - PubMed
    1. Custodis F, Schirmer SH, Baumhakel M, Heusch G, Bohm M, Laufs U. Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol. 2010;56:1973–1983. - PubMed
    1. Investigators G-P Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447–455. - PubMed
    1. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet. 1989;2:757–761. - PubMed

Publication types

Substances

Associated data